Healthtech Startup CurifyLabs Raises €12 Mn in Series A Round

The funding round was co-led by Sandwater and HealthCap, with participation from Tesi (Finnish Industry Investment Ltd.), existing investor Lifeline Ventures, and several customers and employees in the United States. The new funding will help CurifyLabs grow its operations and bring its technology to more healthcare providers.

Read Also- Photonics Startup Aylight Raises €4.5 Mn in Pre-Seed Round

Commenting on the company's growth and future plans, Charlotta Topelius, founder and CEO of CurifyLabs, said: "This investment reflects the conviction our partners have in what we're building. We have set a high bar for clinical rigour, product quality and customer support, and this funding gives us the resources to raise that bar further."

Founded in 2021 by Charlotta Topelius and Niklas Sandler, CurifyLabs develops technology that helps pharmacies prepare personalised medicines automatically. Its Compounding System combines advanced software, high-quality pharmaceutical ingredients, and 3D printing technology to make the medicine preparation process easier.

The platform is designed to make medicine compounding faster, more accurate, and more consistent than traditional manual methods used in pharmacies.

It also includes built-in quality control features to help ensure every medicine is prepared safely, correctly, and with the same high standard every time.

CurifyLabs will use the new funding to expand its operations in the United States. The company also plans to strengthen its supply chain and grow its business in the region.

Part of the investment will be used to improve customer support and speed up the development of new products and technologies.

The funding will also help CurifyLabs continue improving its platform, including the development of its latest product, the PharmaPrinter Aurum.